Physician profile
Brandon L Borer
NPI 1275818056
$2,285.34
in general payments reported to CMS, 2019-2025
18 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $179 · 2021: $92.94 · 2022: $183 · 2023: $125 · 2024: $510 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,312.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,312.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $620.77 | 2019-2020 | |
| Stryker Corporation | $564.26 | 2019-2025 | Augment Injectable, Variax, Prostep Mica |
| Paragon 28, INC. | $284.72 | 2020-2024 | Phantom Hindfoot, Additive Orthopedics |
| Organogenesis INC. | $153.62 | 2019-2023 | Puraply |
| Djo, LLC | $131.77 | 2025 | Cmf |
| Heron Therapeutics, INC. | $80.66 | 2021-2022 | |
| Orthofix Medical, INC. | $64.51 | 2021-2025 | Accelstim, Physio-Stim |
| Conetic Solutions, INC. | $59.12 | 2023-2025 | |
| Integra Lifesciences Corporation | $48.81 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $47.77 | 2021-2023 | V.A.C. Veraflo, V.A.C.Ulta, Activ.A.C. |
| Kerecis Limited | $43.60 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $42.70 | 2024-2025 | V.A.C. Veraflo, Prevena, Activ.A.C. |
| Lifenet Health | $33.63 | 2024 | Theragenesis Wound Matrix |
| Polynovo North America LLC | $29.46 | 2024 | Novosorb Btm |
| Smith+Nephew, INC. | $27.35 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $25.36 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $14.21 | 2025 | Exparel |
| Melinta Therapeutics, LLC | $13.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Borer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.